Orlandi Cesare 4
4 · Lantheus Holdings, Inc. · Filed Dec 3, 2018
Insider Transaction Report
Form 4
Orlandi Cesare
Chief Medical Officer
Transactions
- Sale
Common Stock
2018-11-30$18.00/sh−800$14,400→ 84,864 total - Sale
Common Stock
2018-11-30$18.02/sh−4,058$73,125→ 80,806 total - Sale
Common Stock
2018-11-29$18.00/sh−1,797$32,346→ 86,064 total - Sale
Common Stock
2018-11-29$18.01/sh−400$7,204→ 85,664 total
Footnotes (1)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2018.